Corporate Corruption News Stories
Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
It's estimated that more than 107,000 people in the United States died due to opioid overdoses in 2021. Washington Post journalist Scott Higham notes it's "the equivalent of a 737 Boeing crashing and burning and killing everybody on board every single day." In the new book, American Cartel, Higham and co-author Sari Horwitz make the case that the pharmaceutical industry operated like a drug cartel, with manufacturers at the top; wholesalers in the middle; and pharmacies at the level of "street dealers." The companies collaborated with each other — and with lawyers and lobbyists — to create legislation that protected their industry, even as they competed for market share. "It really is the companies that run the show," Higham says. "People were dying by the thousands while these companies were lobbying members of Congress ... to pass legislation and to lobby members of the Department of Justice and try to slow down the DEA enforcement efforts." Big pharma fought to create legislation that would limit the DEA's ability to go after drug wholesalers. The efforts were effective; more than 100 billion pills were manufactured, distributed and dispensed between 2006 and 2014. Meanwhile, both federal and state DEA agents are frustrated by the ways in which their enforcement efforts have been curtailed. Right now there are 40,000 Americans who are in jail on marijuana charges. And not one executive of a Fortune 500 company involved in the opioid trade has been charged with a crime.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry from reliable major media sources.
Lowering prescription drug prices is among the Biden administration's most urgent priorities. But the drug industry is spending big to keep that from happening. A new compromise on Capitol Hill would offer some relief from high prices by gradually allowing Medicare to negotiate drug prices similar to private insurers for the first time, while capping out of pocket costs at $2,000 and setting limits on the cost of insulin. The pharmaceutical industry has spent nearly $263 million on lobbying so far this year, employing three lobbyists for every member of Congress, according to OpenSecrets, which tracks money in politics. Millions of those dollars are in the form of campaign donations. "They have really endless resources to throw at shaping the outcomes of legislation," said Sheila Krumholz, the executive director of OpenSecrets. Congressman Scott Peters, a Democrat, sparked protests outside his San Diego district office when he came out against a plan to cut drug costs for seniors earlier this year. He's received nearly $130,000 from the industry this year. About $100,000 has been donated to Democratic Senator Kyrsten Sinema this year. Senator Robert Menendez, also a Democrat, has taken nearly $80,000 in 2021. "Bottom line is I'm supporting a price negotiation bill that has been worked out," ... Menendez said when asked what message he's sending by taking money from the pharmaceutical industry.
Note: This article fails to mention that big Pharma spends more than any other sector on lobbying and also is the largest sponsor of advertising in the major media. Do you think the media and Congress are biased by this? For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry from reliable major media sources.
Jeff Smith, a partner with the influential consulting firm McKinsey & Company, accepted a highly sensitive assignment in December 2017. The opioid manufacturer Purdue Pharma ... sought out Dr. Smith. His team reviewed business plans and evaluated new drugs that Purdue hoped would help move the company beyond the turmoil associated with OxyContin, its addictive painkiller that medical experts say helped to spark the opioid epidemic. But the corporate reorganization was not Dr. Smith’s only assignment. He was also helping the Food and Drug Administration overhaul its office that approves new drugs — the same office that would determine the regulatory fate of Purdue’s new line of proposed products. A review ... of internal McKinsey documents found that the firm repeatedly allowed employees who served pharmaceutical companies, including opioid makers, to also consult for the F.D.A., the drug industry’s primary government regulator. And, the documents show, McKinsey touted that inside access in pitches to private clients. In an email in 2014 to Purdue’s chief executive, a McKinsey consultant highlighted the firm’s work for the F.D.A. and stressed “who we know and what we know.” McKinsey also allowed employees advising Purdue to help shape materials that were intended for government officials and agencies, including a memo in 2018 prepared for Alex M. Azar II. References to the severity of the opioid crisis in a draft version of the memo ... were cut before it was sent to Mr. Azar.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry from reliable major media sources.
More than a quarter of the Food and Drug Administration employees who approved cancer and hematology drugs from 2001 through 2010 left the agency and now work or consult for pharmaceutical companies, according to research published by a prominent medical journal. [Dr. Vinay] Prasad and his colleague Dr. Jeffrey Bien ... tracked 55 FDA reviewers in the hematology-oncology field from 2001 through 2010, using LinkedIn, PubMed and other publicly available job data. The researchers found that of the 26 reviewers who left the FDA during this period, 15 of them, or 57 percent, later worked or consulted for the biopharmaceutical industry. Put another way, about 27 percent of the total number of reviewers left their federal oversight posts to work for the industry they previously regulated. Prasad and Bien published their findings as a research letter in The BMJ, formerly The British Medical Journal. "If you know in the back of your mind that your career goal may be to someday work on the other side of the table, I wonder whether that changes the way you regulate," Prasad said. "There's a lot of room for interpretation in deciding whether or not a cancer drug should be approved," he said, because so many studies of cancer drugs rely on what's called a "surrogate endpoint." But ... there isn't always evidence that surrogate endpoints are linked to better health outcomes for patients, suggesting that some approved drugs aren't as beneficial as they appear.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry from reliable major media sources.
The oil and gas industry has delivered $2.8bn (£2.3bn) a day in pure profit for the last 50 years, a new analysis has revealed. The vast total captured by petrostates and fossil fuel companies since 1970 is $52tn, providing the power to “buy every politician, every system” and delay action on the climate crisis, says Prof Aviel Verbruggen, the author of the analysis. The huge profits were inflated by cartels of countries artificially restricting supply. The analysis, based on World Bank data, assesses the “rent” secured by global oil and gas sales, which is the economic term for the unearned profit produced after the total cost of production has been deducted. The study has yet to be published in an academic journal but three experts at University College London, the London School of Economics and the thinktank Carbon Tracker confirmed the analysis as accurate, with one calling the total a “staggering number”. It appears to be the first long-term assessment of the sector’s total profits, with oil rents providing 86% of the total. Emissions from the burning of fossil fuels have driven the climate crisis and contributed to worsening extreme weather. Oil companies have known for decades that carbon emissions were dangerously heating the planet. The average annual profit from 1970-2020 was $1tn but [Verbruggen] said he expected this to be twice as high in 2022. The fossil fuel industry also benefits from subsidies of $16bn a day, according to the International Monetary Fund.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the energy industry and climate change from reliable major media sources.
The CEO of the biggest power company in the US had a problem. A Democratic state senator was proposing a law that could cut into Florida Power & Light’s (FPL) profits. Landlords would be able to sell cheap rooftop solar power directly to their tenants – bypassing FPL and its monopoly on electricity. “I want you to make his life a living hell ... seriously,” FPL’s CEO Eric Silagy wrote in a 2019 email to two of his vice-presidents about state Senator José Javier Rodríguez, who proposed the legislation. Within minutes, one of them forwarded the directive to the CEO of Matrix, LLC, a powerful but little-known political consulting firm that has operated behind the scenes in at least eight states. Rodríguez was ousted from office in the next election. Matrix employees spent heavily on political advertisements for a candidate with the same last name as Rodríguez, who split the vote. That candidate later admitted he was bribed to run. Hundreds of pages of internal documents – which are only coming to light now because Matrix’s founders are locked in an epic feud – detail the firm’s secret work to help power companies like FPL protect their profits and fight the transition to cleaner forms of energy. The Matrix saga illustrates the political obstacles policymakers and experts face as they attempt to cut climate pollution from the power sector. Matrix affiliated groups have also worked to advance power companies’ interests in Arizona, Louisiana, Mississippi, Georgia, and in front of the Environmental Protection Agency, public records show.
Note: A telling analysis shows a 235% profit jump for big oil funded by us at the gas pumps. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the energy industry from reliable major media sources.
The US’s biggest oil companies pumped out record profits over the last few months as Americans struggled to pay for gasoline, food and other basic necessities. On Friday, ExxonMobil reported an unprecedented $17.85bn (£14.77bn) profit for the second quarter, nearly four times as much as the same period a year ago, and Chevron made a record $11.62bn (£9.61bn). The sky-high profits were announced one day after the UK’s Shell shattered its own profit record. The record profits came after similarly outsized gains in the first quarter when the largest oil companies made close to $100bn in profits. High energy prices are one of the leading factors driving inflation to a four-decade high in the US. Gas prices have fallen slightly in recent weeks but are now averaging $4.25 a gallon across the US, more than $1 a gallon higher than a year ago. Soaring energy prices are being baked into delivery costs, which is driving up the cost of everything from apples to toilet paper. In addition to oil company executives, shareholders also reaped the benefits of high energy prices during the quarter. Since the start of 2022, Exxon and Chevron shares have risen close to 46% and 26%, respectively.
Note: A telling analysis shows a 235% profit jump for big oil funded by us at the gas pumps. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the energy industry from reliable major media sources.
Pfizer made nearly $37bn (£27bn) in sales from its Covid-19 vaccine last year – making it one of the most lucrative products in history – and has forecast another bumper year in 2022, with a big boost coming from its Covid-19 pill Paxlovid. The US drugmaker’s overall revenues in 2021 doubled to $81.3bn. The bumper sales prompted accusations from campaigners of “pandemic profiteering”. The group Global Justice Now said the annual revenue of $81bn was more than the GDP of most countries. Pharmaceutical companies have been accused of not sharing the recipe for their vaccines, which would enable drugmakers in poorer countries to produce cheaper versions of them. Global Justice Now pointed out that Pfizer’s Covid-19 jab was invented by BioNTech, supported by €100m (£84m) in debt financing from the publicly owned European Investment Bank and a €375m grant from the German government. Tim Bierley, a pharma campaigner at the group, said: “The development of mRNA vaccines should have revolutionised the global Covid response. “But we’ve let Pfizer withhold this essential medical innovation from much of the world, all while ripping off public health systems.” According to Reuters, Pfizer has sold the vaccine to African countries at $3 to $10 a shot. It has indicated that a non-profit dose costs just $6.75, or £4.98, to produce, but it has reportedly charged the NHS £18 a dose for the first 100m jabs bought and £22 a dose for the next 89m, totalling £3.76bn ... amounting to an eye-watering 299% mark-up.
Note: If big Pharma really cared about public healthy, don’t you think they’d be willing to sacrifice some of their huge profits and charge much less for their injections? Unfortunately, it’s the old story of the rich get richer and the rest are left behind. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering from reliable major media sources.
Medicare’s drug program could have saved up to $3.6 billion in 2020 by mirroring the pricing strategy of entrepreneur and Shark Tank judge Mark Cuban’s online pharmacy, according to a new study. Cuban’s Cost Plus Drug Co. offers a selection of generic drugs at the cost of manufacturing them plus a flat 15% markup. The direct-to-consumer pharmacy does not accept insurance. The study’s authors suggest that Medicare is overpaying for many generic drugs and could save billions a year if it purchased them directly from Cuban’s online pharmacy. “The lower prices from a direct-to-consumer model highlight inefficiencies in the existing generic pharmaceutical distribution and reimbursement system, which includes wholesalers, pharmacy benefit managers, pharmacies, and insurers,” wrote researchers at Brigham and Women’s Hospital and Harvard Medical School in a brief published ... in the journal Annals of Internal Medicine. Cuban and his pharmacy did not fund or have any involvement in the study. Cost Plus Drug Co. says it engages in price negotiations with drugmakers. Medicare’s drug program, Part D, however, prohibits the government from directly negotiating pharmaceutical prices. Researchers compared 2020 Medicare spending for a total of 89 drugs ... to their prices at Cost Plus Drug Co. in February. They estimate that Medicare overpaid for 77 generic drugs, spending $8.1 billion compared with $4.5 billion if the federal agency had purchased at the same prices as Cost Plus Drug Co. charges.
Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and Big Pharma profiteering from reliable major media sources.
On September 19, 2019, House Speaker Nancy Pelosi introduced the Elijah Cummings Lower Drug Costs Now Act. The bill ... would allow the federal government to negotiate drug prices on behalf of Medicare, a right assumed by the governments of every other major economy. Polls showed support ranging from 80 to an eye-popping 90-plus percent. H.R. 3 was delivered stillborn into Mitch McConnell’s Senate in November of 2019. Two years later, when Joe Biden released the massive social-spending and climate-change bill dubbed Build Back Better, H.R. 3’s reforms were nowhere to be found. And at every level of government, Pharma’s endless river of money continues to flow, the widest, steadiest current of lobbying largesse the capitol has ever known. In 2021, the industry reported spending $124 million on a fleet of 846 lobbyists, roughly two for every member of Congress. Sixty-five percent were former government employees. Pharmaceutical manufacturers are part of a larger coalition that includes the insurance, medical-device, and hospital industries. Its combined resources flow downstream through dozens of lobbying firms, communications shops, and front groups. “If a freshman Democrat so much as signs a letter related to drug prices, the lobby hammers them with phone calls and meeting requests, completely locking up the calendar,” says Alex Lawson, executive director of Social Security Works. “The calls come in from ex-Democratic officials and staffers, so they have to take the meetings.”
Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and Big Pharma profiteering from reliable major media sources.
Why have so many smart, well-trained doctors stood by as American healthcare descended into a state of profound dysfunction? The answer lies in the gradual, nearly invisible commercial takeover of the medical “knowledge” that doctors are trained to trust. In 1981, President Ronald Reagan slashed government support of university-based medical research. Following the 1980 passage of the University and Small Business Patent Procedures Act, nonprofit institutions and their researchers were allowed to benefit financially from the discoveries made while conducting federally funded research. Over the past few decades, the drug companies have taken over most of our clinical research. In 1991, academic medical centers (AMCs)—hospitals that train doctors and conduct medical research—received 80 percent of the money that industry was spending to fund clinical trials. But by 2004, the percentage of commercially funded clinical trials conducted by AMCs had fallen from 80 to just 26 percent. That ... allowed the commercial funder to own, and thus control, the data from jointly conducted research. Unbeknownst to almost all doctors, peer reviewers are not granted access to the underlying data that serves as the basis for the reported findings. The drug companies own that data and keep it confidential. Reviewers must rely on brief data summaries. Peer reviewers at even the most prestigious medical journals cannot possibly attest to the accuracy and completeness of the articles they review.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in science and Big Pharma profiteering from reliable major media sources.
When the Federal Reserve needed Wall Street’s help with its pandemic rescue mission, it went straight to Larry Fink. The BlackRock cofounder, chairman, and chief executive officer has become one of the industry’s most important government whisperers. The company’s new assignment is a much bigger version of one it took on after the 2008 financial crisis, when the Federal Reserve enlisted it to dispose of toxic mortgage securities. This time it will help the Fed prop up the entire corporate bond market by purchasing, on the central bank’s behalf, what could become a $750 billion portfolio of debt. One part of the Fed’s plan is to buy bond exchange-traded funds. BlackRock itself runs ETFs under the iShares brand, and could end up buying funds it manages. “BlackRock is acting as a fiduciary to the Federal Reserve Bank of New York,” says a spokesman for the company. “As such, BlackRock will execute this mandate at the sole discretion of the bank.” The arrangement is bringing new attention to the company’s scale and ubiquity. “It’s impossible to think of BlackRock without thinking of them as a fourth branch of government,” says William Birdthistle, a professor at the Chicago-Kent College of Law. BlackRock’s growth raises questions over how big and useful a company can become before its size poses a risk. And then there are the potential conflicts. One arm of BlackRock knows what the Fed is buying, while other parts of the business participating in credit markets could benefit from that knowledge.
Note: Watch an excellent documentary showing how BlackRock, Vanguard, and several other institutions are the largest shareholders in almost every major corporation you can think of. For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the financial industry from reliable major media sources.
"It's like a horror movie I'm being forced to watch and I can't close my eyes," one senior FDA official lamented. That particular FDA doctor was referring to two recent developments inside the agency. First, how, with no solid clinical data, the agency authorized COVID vaccines for infants and toddlers, including those who already had COVID. And second, [how] the FDA bypassed its external experts to authorize booster shots for young children. That doctor is hardly alone. At the NIH, doctors and scientists complain to us about low morale and lower staffing: The NIH's Vaccine Research Center has had many of its senior scientists leave over the last year, including the director, deputy director and chief medical officer. The CDC has experienced a similar exodus. "There's been a large amount of turnover. Morale is low," one high level official at the CDC told us. "Things have become so political, so what are we there for?" Another CDC scientist told us: "I used to be proud to tell people I work at the CDC. Now I'm embarrassed." Why are they embarrassed? First, they demanded that young children be masked in schools. On this score, the agencies were wrong. Compelling studies later found schools that masked children had no different rates of transmission. Next came school closures. The agencies were wrong – and catastrophically so. Poor and minority children suffered learning loss with an 11-point drop in math scores alone and a 20% drop in math pass rates. Then they ignored natural immunity. Wrong again.
Note: Why are so few media reporting on this most important news? For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus from reliable major media sources.
Pension funds, investment firms and Wall Street banks are snapping up family homes in Europe and the United States at a rapid pace as prices rocket higher. At the same time, the soaring cost of home ownership means that growing numbers of younger Americans and Brits renting rather than buying houses as they start families. Some of them may find their next landlord is based on Wall Street or in London's financial district. Analysts argue that this will improve standards in the rental sector. But some tenants who rent from corporate landlords dispute this, alleging substandard services and excessive rent increases. If investors are hoovering up existing properties that would otherwise have been sold to individuals, that could squeeze out first-time buyers. Household incomes in the United States and United Kingdom have not kept pace with rising home values in recent years, a trend made worse by the pandemic, which has sent average house prices in both markets to record highs. Invitation Homes, America's biggest single-family home leasing company with some 81,000 houses, is currently facing two lawsuits brought by tenants in California and Maryland who claim that the company's late rent fees constitute illegal penalties under state laws. Current and former tenants of the company ... painted a picture of an uncaring landlord, slow to make repairs and quick to threaten eviction when rent payments are overdue or withheld because of unresolved maintenance issues.
Note: For more along these lines, see concise summaries of deeply revealing news articles on financial industry corruption and income inequality from reliable major media sources.
The US Supreme Court let stand an $87 million award against Bayer AG, rejecting the company for the second time in a week as it tries to fend off tens of thousands of claims that its top-selling Roundup weedkiller causes cancer. The justices, making no comment, on Monday left in place a jury’s finding in favor of Alva and Alberta Pilliod in a California case. Bayer argued that a federal law precluded the suit and that the $70 million punitive damages award was so large it violated the Constitution. The court last week rejected Bayer’s appeal in a case the company was trying to use to scuttle billions of dollars in potential claims. The company’s liability could be the full $16 billion it has set aside to resolve the litigation, according to Bloomberg Intelligence analyst Holly Froum. Earlier this month, a federal appeals court ordered the US Environmental Protection Agency to take another look at whether glyphosate - Roundup’s active ingredient - is a carcinogen. Studies have linked it to some cancers. The German chemicals giant said it “is fully prepared to manage the litigation risk associated with potential future claims in the US as previously communicated in July 2021, including a voluntary claims program, transition of active ingredients for glyphosate-based products in the US.” Bayer inherited the legal mess in 2018 when it acquired Monsanto Co., the herbicide’s maker. Bayer has won four of seven Roundup trials so far, with all its losses occurring in California courts. The case is Monsanto v. Pilliod, 21-1272.
Note: Instead of relying on independent science, the EPA used industry studies to determine that glyphosate was safe. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health from reliable major media sources.
California will begin making its own low-cost insulin in an effort to make the essential diabetes treatment more affordable, Gov. Gavin Newsom announced on Thursday. “Nothing epitomizes market failures more than the cost of insulin,” the governor said in a video posted on Twitter, “Many Americans experience out-of-pocket costs anywhere from three hundred to five hundred dollars per month for this life-saving drug.” With a budget of $100 million, California plans to “contract and make our own insulin at a cheaper price, close to at cost, and to make it available to all,” Newsom said. It’s unclear exactly how inexpensive California’s insulin will be or when the low-cost drugs will be available. Insulin in the U.S. costs almost $100 per unit, on average. That’s nearly four times the price in Chile, which has the second-highest prices among the 34 countries analyzed by the nonprofit Rand Corporation, at less than $25 per unit. Currently, four in five Americans in need of insulin have incurred thousands of dollars in credit card debt to pay for the medication, according to a recent survey commissioned by health care organization CharityRx. The average debt among all survey participants was $9,000. California’s program will allot $50 million toward the development of cheaper insulin products and $50 million on an in-state insulin manufacturing facility, Newsom said, adding that the facility “will provide new, high-paying jobs and a stronger supply chain for the drugs.”
Note: The unethical corruption of big Pharma is so clearly seen in the ridiculously inflated prices of drugs in the US compared to other countries. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering from reliable major media sources.
Nightmare stories of nurses giving potent drugs meant for one patient to another and surgeons removing the wrong body parts have dominated recent headlines about medical care. Lest you assume those cases are the exceptions, a new study by patient-safety researchers provides some context. Their analysis, published in the BMJ ... shows that “medical errors” in hospitals and other health-care facilities are incredibly common and may now be the third-leading cause of death in the United States — claiming 251,000 lives every year, more than respiratory disease, accidents, stroke and Alzheimer’s. Martin Makary, a professor of surgery at the Johns Hopkins University School of Medicine ... led the research. Makary’s research involves a ... comprehensive analysis of four large studies, including ones by the Health and Human Services Department’s Office of the Inspector General and the Agency for Healthcare Research and Quality that took place between 2000 to 2008. His calculation of 251,000 deaths equates to nearly 700 deaths a day — about 9.5 percent of all deaths annually in the United States. Although all providers extol patient safety and highlight the various safety committees and protocols they have in place, few provide the public with specifics on actual cases of harm due to mistakes. Moreover, the Centers for Disease Control and Prevention doesn’t require reporting of errors in the data it collects about deaths through billing codes, making it hard to see what’s going on at the national level.
Note: Read lots more about this disturbing fact. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health from reliable major media sources.
The Supreme Court has rejected Bayer’s appeal to shut down thousands of lawsuits claiming that its Roundup weed killer causes cancer. The justices on Tuesday left in place a $25-million judgment in favor of Edwin Hardeman, a California man who says he developed cancer from using Roundup for decades to treat poison oak, overgrowth and weeds on his San Francisco Bay Area property. Hardeman’s lawsuit had served as a test case for thousands of similar lawsuits. The high court’s action comes amid a series of court fights over Roundup that have pointed in different directions. On Friday, a panel of the U.S. 9th Circuit Court of Appeals rejected an Environmental Protection Agency finding from 2020 that glyphosate does not pose a serious health risk and is “not likely” to cause cancer in humans. The appellate court ordered the EPA to reexamine its finding. At the same time, Bayer has won four consecutive trials in state court against people who claimed they got cancer from Roundup. The latest verdict in favor of the pharmaceutical company came last week in Oregon. The EPA says on its website that there is “no evidence that glyphosate causes cancer in humans.” But in 2015, the International Agency for Research on Cancer, part of the World Health Organization, classified glyphosate as ”probably carcinogenic to humans.” The agency said it relied on “limited” evidence of cancer in people and “sufficient” evidence of cancer in study animals.
Note: Instead of relying on independent science, the EPA used industry studies to determine that glyphosate was safe. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health from reliable major media sources.
Facebook prohibits gun sales on its service. But buyers and sellers can violate the rule 10 times before they are kicked off the social network, according to internal guidance obtained by The Washington Post. The policy, which has not previously been reported, is much more lenient than for users who post child pornography, which is illegal, or a terrorist image, which prompts immediate removal from the platform. A separate, five-strikes policy extends even to gun sellers and purchasers who actively call for violence. Facebook’s gun policies have long been a source of contention among the company’s senior leadership and policymaking teams, who have been torn between the platform’s support of free speech and public pressure to curtail weapons sales. Gun sellers have seized on loopholes within Facebook’s policy. Journalists have repeatedly uncovered strategies sellers use to evade bans while reaching potential customers in dedicated Facebook groups or on Facebook Marketplace, the company’s classified services. One tactic is advertising gun accessories, like holsters or cases, which are permitted for sale on the platform; once a customer contacts the seller, a gun can be sold in Facebook’s private messages. After responding to several listings for gun cases, a Post reporter received three private messages with offers to purchase a gun. Joel Kaplan, vice president of global public policy ... said that banning transactions of a product that was both legal and highly popular would alienate the political right.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.
Matt Litrell, a 22-year-old Amazon employee, was distributing union fliers outside the warehouse where he works this month when the cops showed up. An Amazon manager had called the sheriff’s office in Campbellsville, Ky., that afternoon to report that protesters trying to start a union were trespassing on company property. While the officers eventually determined that Litrell wasn’t on Amazon’s property and left, Litrell plans to add the incident to the illegal-intimidation charge he filed with the National Labor Relations Board in May. Employees at Amazon facilities around the country whose union hopes were buoyed by the labor victory at a warehouse in Staten Island in April say in labor board filings and interviews that the company has been calling police, firing workers and generally cracking down on labor organizing since that historic win. Amazon has been accused of illegally firing workers in Chicago, New York and Ohio, calling the police on workers in Kentucky and New York, and retaliating against workers in New York and Pennsylvania, in what workers say is an escalation of long-running union-busting activities by the company. It’s a sign that, even as lawmakers demand Amazon drop its objections to the union win in Staten Island ... the nation’s second-largest private employer will continue to put up fierce opposition to any wave of union momentum. Eric Milner, a lawyer representing the Amazon Labor Union, called the company’s objections to the election “a frivolous sideshow.”
Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.
Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
